标题
Mitochondrial targeted peptides for cancer therapy
作者
关键词
Mitochondria, Peptide, Cancer, Review
出版物
TUMOR BIOLOGY
Volume 36, Issue 8, Pages 5715-5725
出版商
Springer Nature
发表日期
2015-07-04
DOI
10.1007/s13277-015-3719-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Paradoxical action of reactive oxygen species in creation and therapy of cancer
- (2014) Sina Kardeh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oxytocin has therapeutic effects on cancer, a hypothesis
- (2014) Mohammad Hossein Imanieh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metastasis review: from bench to bedside
- (2014) Ali Mohammad Alizadeh et al. TUMOR BIOLOGY
- A specific cell-penetrating peptide induces apoptosis in SKOV3 cells by down-regulation of Bcl-2
- (2013) Chuying Ma et al. BIOTECHNOLOGY LETTERS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
- (2013) François Vaillant et al. CANCER CELL
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia
- (2013) T Prezma et al. Cell Death & Disease
- killerFLIP: a novel lytic peptide specifically inducing cancer cell death
- (2013) B Pennarun et al. Cell Death & Disease
- Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
- (2013) R. Pan et al. Cancer Discovery
- Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
- (2012) S. X. Ren et al. CANCER RESEARCH
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery
- (2012) Zhi Li et al. Journal of Translational Medicine
- Oxytocin protects cardiomyocytes from apoptosis induced by ischemia–reperfusion in rat heart: Role of mitochondrial ATP-dependent potassium channel and permeability transition pore
- (2012) Ali Mohammad Alizadeh et al. PEPTIDES
- The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart
- (2012) Mahdieh Faghihi et al. PEPTIDES
- Bax regulates primary necrosis through mitochondrial dynamics
- (2012) R. S. Whelan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial pharmacology
- (2012) Robin A.J. Smith et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
- (2012) R W Rooswinkel et al. Cell Death & Disease
- HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells
- (2011) Gui‑Rong Yu et al. BIOSCIENCE REPORTS
- Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH
- (2011) L. Yin et al. BLOOD
- Calcium and cell death mechanisms: A perspective from the cell death community
- (2011) Boris Zhivotovsky et al. CELL CALCIUM
- Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
- (2011) Jean-Claude Martinou et al. DEVELOPMENTAL CELL
- Oncolytic Activities of Host Defense Peptides
- (2011) Sammy Al-Benna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dependence on the MUC1-C Oncoprotein in Non-Small Cell Lung Cancer Cells
- (2011) D. Raina et al. MOLECULAR CANCER THERAPEUTICS
- Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction
- (2010) F. Zhong et al. BLOOD
- The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
- (2010) Scott Ackler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
- (2010) Paul K. Paik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Host defense peptides and their antimicrobial-immunomodulatory duality
- (2010) Lars Steinstraesser et al. IMMUNOBIOLOGY
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program
- (2010) D. Ren et al. SCIENCE
- Cell Death Mechanisms and Their Implications in Toxicology
- (2010) Sten Orrenius et al. TOXICOLOGICAL SCIENCES
- The Cell Death-Inducing Activity of the Peptide Containing Noxa Mitochondrial-Targeting Domain Is Associated with Calcium Release
- (2009) Y.-W. Seo et al. CANCER RESEARCH
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Recent Advances in Cancer Therapy: An Overview
- (2009) A. Urruticoechea et al. CURRENT PHARMACEUTICAL DESIGN
- Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer
- (2009) Chi-Mu Chuang et al. HUMAN GENE THERAPY
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
- (2008) Hyun Soo Lee et al. CANCER LETTERS
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death
- (2008) E Norberg et al. CELL DEATH AND DIFFERENTIATION
- Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim
- (2008) A M Jabbour et al. CELL DEATH AND DIFFERENTIATION
- Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
- (2008) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
- (2008) A. R. Shoemaker et al. CLINICAL CANCER RESEARCH
- Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation
- (2008) Min H. Kang et al. JNCI-Journal of the National Cancer Institute
- Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
- (2008) K E Tagscherer et al. ONCOGENE
- Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels
- (2008) Federica Chiara et al. PLoS One
- Mitochondria in cancer: Not just innocent bystanders
- (2008) Christian Frezza et al. SEMINARS IN CANCER BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now